Chronic Obstructive Pulmonary Disease (COPD) Treatment market
Free Online Advertising
Free Internet Web Site Advertising.
UK Free Classifieds
United Kingdom Free Ads Website.
100% Free Ad Posting.
Canada Free Ads
Popular Online Classifieds in Canada.
No Sign up, No Email Required to Post.
The Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is expected to grow from US$ XXBn in 2019 to USD XX Bn by 2026, at a CAGR of 4.1% during the forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology :- Request Free Sample Report
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics. There are several lifestyle-related factors such as smoking, exposure to biomass fuel, and air pollution, which increase the risk of developing COPD. In addition to tobacco smoke, there are other factors such as occupational exposure, outdoor pollution. Exposure to second-hand or passive smoking. Smoke from the burning of biomass, respiratory infections, poor nutritional status, chronic asthma, impaired lung growth, poor socio-economic status and dietary factors, which lead directly or indirectly to COPD.
Increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and incidence of respiratory diseases i.e., asthma, and cystic fibrosis is expected to drive the market growth during the forecast period. However, emerging markets and growth in online marketing channel offers opportunities for the market. New drug development by market players through collaborations and increase in research and development expenditure are anticipated to drive the global market. Propeller Health and Novartis Pharma AG entered into collaboration to develop a custom add-on sensor for the Breezhaler inhaler, a device indicated for COPD treatments.
Rise in number of public and private organizations is another major factor propelling the growth of COPD Treatment market. For instance, organizations such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged in providing information in clinical and basic research on allergy, asthma, and clinical immunology. Such initiatives are in turn expected to increase the market in developing regions, thereby boosting overall market growth.
There is a lack of knowledge and awareness about COPD especially in the developing countries due to which primary care practitioners (PCPs) and other healthcare providers delay or incorrectly diagnose COPD. Another major factor contributing to the poor diagnosis of COPD is the diagnostic confusion between COPD and asthma. Thus, poor or incorrect diagnosis is a major challenge as it prevents people with COPD from getting a proper diagnosis which, in turn, has a negative impact on market growth.
|Related Link: Click here to visit item owner's website (0 hit)|
|Target Nation: All Nations|
Target City : pune
Last Update : 22 May 2021 8:08 AM
Number of Views: 121
|Item Owner : aarti|
Contact Phone: (None)
|Friendly reminder: Click here to read some tips.|